federal_register: 2026-09808
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09808 | Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment | Notice | The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to develop hetIL-15 in combination with other agents, such as PPARa agonists (Fenofibrate), FLT3 inhibitors (quizartinib), IL-12, or chemotherapy into a therapeutic for cancer. | 2026-05-15 | 2026 | 5 | https://www.federalregister.gov/documents/2026/05/15/2026-09808/government-owned-inventions-available-for-license-synergistic-interactions-for-improved-cancer | https://www.govinfo.gov/content/pkg/FR-2026-05-15/pdf/2026-09808.pdf | Health and Human Services Department; National Institutes of Health | 221,353 | The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to develop hetIL-15 in combination with other agents, such as PPARa agonists (Fenofibrate), FLT3 inhibitors (quizartinib), IL-12, or chemotherapy into a... |